Secondary Stock Offerings
By The Online Investor Staff, updated Fri., Jun. 9, 7:35 AM
| This Slide: #2 of 25 |
Slide #2. Akoya Biosciences, Inc. — Secondary Offering
Company:
Akoya Biosciences, Inc. (NASDAQ:AKYA)
Date announced:
6/7/2023
Shares Offered:
8,700,000
Date of Pricing:
6/8/2023
Price Per Share:
$5.00
Secondary Offering Details:
Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, today announced it has launched an underwritten public offering of shares of its common stock (the "Offering"). In addition, Akoya expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. -updated 6/8- Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, today announced the pricing of its public offering of 8,700,000 shares of common stock (the "Offering") at a public offering price of $5.00 per share for gross proceeds of approximately $43.5 million, without giving effect to the underwriting discount and commission as well as estimated expenses payable by Akoya. Akoya has granted the underwriters a 30-day option to purchase up to an additional 1,305,000 shares of its common stock at the public offering price. The closing of the Offering is expected to occur on June 12, 2023, subject to the satisfaction of customary closing conditions.
Akoya Biosciences is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Spatial biology is an evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler™ and PhenoImager™ platforms, reagents, software and services, Co. provides solutions to perform tissue analysis and spatial phenotyping across the continuum from discovery through translational and clinical research.
Open the AKYA Page at The Online Investor »
|
|||||||||||||||||||||
Open the AKYA Page at The Online Investor (in a new window) »
 Free AKYA Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.93 out of 4) 73rd percentile
(ranked higher than approx. 73% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
